OTCMLVGI
Market cap288kUSD
Dec 26, Last price
0.00USD
1D
0.00%
1Q
-9.09%
Jan 2017
33.33%
Name
Limitless Venture Group Inc
Chart & Performance
P/E
—
P/S
0.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
94.65%
Rev. gr., 5y
%
Revenues
2m
+26.87%
Net income
-260k
L-85.77%
CFO
45k
P
Profile
Limitless Venture Group Inc., a development stage company, produces, distributes, and markets body care, health, and alcoholic products. The company offers LIMITLESS BODY products, including BODY FRESH, a body wash; MUSCLE BUTTER, a body soothing massage butter; BODY SUGAR, a sugar body scrub; BARE SKIN, a moisturizing shave cream; and GYM SANI-T, a sanitizer. It also provides LIMITLESS HEALTH products, such as Prostaderol, a natural prostate health supplement; LipiRestorin; and Maxtlevelin, a product to increase testosterone levels. In addition, the company offers HempCore health products comprising RELAX, an anxiety relief formula; FIBER UP to remove toxins; HEALTHY HEART, a natural product that promotes cardiovascular health and helps maintain healthy cholesterol levels; BRAIN BOOST, a neurotransmitter boosting formula that assists central nervous system to deliver oxygen and nutrients to the brain; and JOINT RELEIF, an anti-inflammation joint formula used to rebuild, lubricate, and soothe aching joints. Further, it provides ready to drink alcoholic shots that include Haymaker, a vodka with lemon and tea flavors; CoCo-Puff, a vodka with chocolate and Irish cream flavors; Red Headed Slut, a vodka with peach, licorice, and cranberry flavors; Twist, a tequila with lime flavor; and Kamikaze, a vodka with orange liquor and lime flavors. The company was formerly known as Enerbrite Technologies Group Inc. and changed its name to Limitless Venture Group Inc. in February 2013. Limitless Venture Group Inc. is based in Tulsa, Oklahoma.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
| Income | |||||||||
Revenues | 1,716 26.87% | 1,353 -14.90% | 1,589 194.77% | ||||||
Cost of revenue | 736 | 745 | 1,017 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 980 | 608 | 572 | ||||||
NOPBT Margin | 57.11% | 44.94% | 35.99% | ||||||
Operating Taxes | 180 | (151) | (275) | ||||||
Tax Rate | 18.37% | ||||||||
NOPAT | 800 | 759 | 847 | ||||||
Net income | (260) -85.77% | (1,830) 18.96% | (1,539) 65.16% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 50 | 145 | |||||||
BB yield | -56.52% | -72.63% | |||||||
| Debt | |||||||||
Debt current | 3,158 | 2,924 | 2,753 | ||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 65 | 65 | 75 | ||||||
Net debt | 3,076 | 2,903 | 2,633 | ||||||
| Cash flow | |||||||||
Cash from operating activities | 45 | (858) | (515) | ||||||
CAPEX | 4 | ||||||||
Cash from investing activities | 393 | ||||||||
Cash from financing activities | 15 | 367 | 519 | ||||||
FCF | 390 | 1,166 | 2,042 | ||||||
| Balance | |||||||||
Cash | 81 | 21 | 120 | ||||||
Long term investments | |||||||||
Excess cash | 41 | ||||||||
Stockholders' equity | (22,734) | (22,654) | (21,650) | ||||||
Invested Capital | 21,035 | 20,544 | 20,494 | ||||||
ROIC | 3.85% | 3.70% | 4.24% | ||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 360,955 | 69,387 | 17,063 | ||||||
Price | 0.00 -68.63% | 0.00 -89.10% | 0.01 -84.49% | ||||||
Market cap | 144 63.20% | 88 -55.68% | 200 -79.73% | ||||||
EV | 1,802 | 1,880 | 1,522 | ||||||
EBITDA | 980 | 613 | 655 | ||||||
EV/EBITDA | 1.84 | 3.07 | 2.32 | ||||||
Interest | 435 | 503 | 688 | ||||||
Interest/NOPBT | 44.34% | 82.70% | 120.21% | ||||||